We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Published in Diabetes

Journal Scan / Research · January 10, 2023

Circulating FGF21 Concentration, Fasting Plasma Glucose Concentration, and the Risk of Type 2 Diabetes

The Journal of Clinical Endocrinology and Metabolism

 

 Save  Recommend
 Share

Additional Info

The Journal of Clinical Endocrinology and Metabolism
Circulating FGF21 Concentration, Fasting Plasma Glucose and the Risk of Type 2 Diabetes: Results from the PREVEND study
J. Clin. Endocrinol. Metab. 2022 Dec 19;[EPub Ahead of Print], A Post, WA Dam, S Sokooti, D Groothof, J Gloerich, AJ van Gool, D Kremer, RT Gansevoort, J van den Born, IP Kema, CFM Franssen, RPF Dullaart, SJL Bakker

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated